APA (7th ed.) Citation

TH, Y., Y, K., A, P., P, N., & RW, L. (2024). Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply. Alimentary pharmacology & therapeutics, 60(1), 103. https://doi.org/10.1111/apt.18057

Chicago Style (17th ed.) Citation

TH, Yiu, Ko Y, Pudipeddi A, Natale P, and Leong RW. "Letter: Early Real-world Evidence from the United Arab Emirates of the Persistence, Effectiveness and Safety of Risankizumab for the Treatment of Crohn's Disease-Authors' Reply." Alimentary Pharmacology & Therapeutics 60, no. 1 (2024): 103. https://doi.org/10.1111/apt.18057.

MLA (9th ed.) Citation

TH, Yiu, et al. "Letter: Early Real-world Evidence from the United Arab Emirates of the Persistence, Effectiveness and Safety of Risankizumab for the Treatment of Crohn's Disease-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 60, no. 1, 2024, p. 103, https://doi.org/10.1111/apt.18057.